Cite

    Bolinder, J. et al. (n.d.). Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin. Diabetes, obesity & metabolism. 16 (2), pp. 159-169. [Online].